Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 3/20 | 0.39 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.39 |
| ▸ | GPR119 | Q8TDV5 | 11/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 9/20 | 0.39 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.38 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.35 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20060866 | 0.88 | GPR119 (0.44) | NR1H2NR1H3GPR119HCRTR1HCRTR2 | |
| SCHEMBL20060918 | 0.84 | NR1H2 (0.54) | NR1H2NR1H3GPR119KCNH2HCRTR1 | |
| SCHEMBL20068735 | 0.84 | NR1H2 (0.54) | NR1H2NR1H3GPR119KCNH2HCRTR1 | |
| SCHEMBL22311101 | 0.83 | NR1H2 (0.44) | NR1H2NR1H3KCNH2FFAR1PDK2 | |
| SCHEMBL20068695 | 0.82 | HCRTR1 (0.36) | NR1H2NR1H3GPR119HCRTR1HCRTR2 | |
| SCHEMBL20060908 | 0.82 | GPR119 (0.44) | GPR119KCNH2 | |
| SCHEMBL20061055 | 0.79 | GPR119 (0.47) | NR1H2NR1H3GPR119HRH3PDK2 | |
| SCHEMBL20060927 | 0.79 | GPR119 (0.47) | NR1H2NR1H3GPR119HRH3PDK2 | |
| SCHEMBL22311072 | 0.79 | GPR119 (0.47) | NR1H2NR1H3GPR119KCNH2HCRTR1 | |
| SCHEMBL20060910 | 0.79 | GPR119 (0.47) | NR1H2NR1H3GPR119KCNH2HCRTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018068295-A1 | ARYL AND HETEROARYL ETHER DERIVATIVES AS LIVER X RECEPTOR β AGONISTS, COMPOSITIONS, AND THEIR USE | MERCK SHARP & DOHME CORP. (US) | 2018-04-19 | — | — | WO | disclosed |